News

Initiative will bring together venture capitalists, startups and government officials, Deputy Secretary Eric Hargan said.

Key European eHealth interoperability experts gathered in Brussels, Belgium, last week to discuss a multi-stakeholder initiative that could allow a one-time interoperability testing of eHealth products with mutual recognition across the EU and beyond. New usages, new technologies, an ageing population and many other factors have contributed to a change in healthcare, leading to more connectivity between systems and an increasing need for interoperability. Organised by the EURO-CAS project partners under the Horizon 2020 European research and innovation programme, including, among others, Integrating the Healthcare Enterprise Europe (IHE Europe), Agence eSanté Luxembourg, the European Institute for Biomedical Imaging Research (EIBIR) and Personal Connected Health Alliance (PCHAlliance), attendees looked at the potential use and scale of introducing a Conformity Assessment Scheme for Europe (CASforEU) based on existing well-used norms and standards to overcome interoperability challenges in the healthcare sector. Webinar: Interoperability Sets the Foundation for Care Coordination Dr Ceri Thomson, Head of Policy Sector, eHealth, Well-Being and Ageing at DG Connect, European Commission, stressed the importance of breaking down data silos and estimated that CASforEU could contribute to the key pillars for the transformation of digital health and care.  There are currently several examples of best practice of cross-border health information exchanges in the field of ePrescriptions and patient summaries that could be extended to other use cases, such as laboratory tests, images, discharge letters – but these are all subject to fundamental underpinning infrastructures being in place, Dr Thomson explained. CASforEU governance. Source: EURO-CAS project “Workshops in several Members States confirmed the need for pragmatic interoperability testing, and CASforEU as a solution," said Karima Bourquard, IHE-Europe Director of Interoperability. Assessing conformance to a common set of standards is critical for the future. A scheme like CASforEU could avoid costly and time-consuming need for re-testing across different countries and regions, it was argued. “The EURO-CAS Organization will drive CASforEU and be the place where procurers, vendors, users and all interested parties from all Europe can meet to ensure optimal applicability," added Samuel Danhardt, Interoperability Expert at Agence eSanté Luxembourg. For more harmonisation, CASforEU will be aligned with other existing international schemes, such as IHE-CAS and PCHAlliance’s Continua Certification, relying on ISO/IEC 17025 accredited test laboratories for EU-wide recognition. As discussed at the meeting, when put in practice, healthcare providers could procure CASforEU products or request testing before buying to ensure interoperability, and vendors would only need to do the CASforEU test once to access the Digital Single Market. Anett Molnar is a Senior Manager, Public Policy and Engagement, for HIMSS EMEA.

Health Minister Datuk Seri Dr Dzulkefly Ahmad also said in a recent HIMSS TV interview that even if an organisation has a good programme and system in place, digitising healthcare will not succeed if there is no clinical buy-in underpinned by training.

From the research lab to the bedside to the back office, AI and machine learning are transforming the ways we think about care and how we develop treatments.

Biofourmis, a Singapore-based health analytics platform, has entered into a collaboration with Brigham and Women’s Hospital in Boston, US to co-develop improvements to their proprietary analytics engine, Biovitals™ for Brigham’s Home Hospital Programme. Patients are cared for in their home instead of the hospital in Brigham’s Home Hospital Programme, with the aim of providing the right care to the patient at the right time and place. The Programme started in November 2016 and about 200 patients have been cared for from home so far. The process After a patient has been discharged from the hospital, a doctor or nurse meets the patient at his or her home and all diagnostic work are performed at home, such as blood tests, X-rays and ultrasounds. The patient’s vitals including heart and respiratory rate, as well as movement are monitored 24/7 with wireless monitoring technology. The patient is given an electronic tablet that allows him or her to communicate anytime with medical staff via phone, text or on-demand video. Many treatments, including medications, are administered at a patient’s bedside. Preliminary pilot data of nine patients who were randomised to receive care at home showed that the average direct cost for acute care episodes for home patients was up to half of the cost of the control patients cared for in the hospital. Webinar: Patient Engagement: Transforming the Patient Experience with Innovative Digital Services The collaboration between Biofourmis and Brigham and Women’s Hospital will harness and clinically utilise the vast quantity of biometric data that the home hospital team collects. The team plans use the Biovitals™ analytics engine and further innovate around new predictive algorithms. Unlike traditional threshold-based physiology monitoring, Biovitals™ uses advanced machine learning to learn a patient’s physiology and then dynamically build a personalised physiology signature that can detect subtle physiological changes that may predict a patient’s health. The programme would also use Biofourmis’ RhythmAnalytics™ platform to detect dozens of different cardiac arrhythmias. “Current remote monitoring systems are based on univariate physiology analysis and have shown high false alarm burden and no early intervention, especially while monitoring patients in an ambulatory setting. This collaboration would enable us to enhance and co-develop new predictive models for monitoring acutely ill patients’ suffering from multiple conditions like heart failure, pneumonia, COPD, and atrial fibrillation at-home, enabling clinicians to intervene early and improve the level of safety of patients,” said Kuldeep Singh Rajput, Founder & CEO of Biofourmis. “Our home hospital team is hoping to improve care for our patients by creating a suite of highly clinically-useful algorithms that can predict deterioration and improvement for those who are acutely ill,” said David Levine MD, MPH, MA, researcher and lead for Brigham and Women’s Home Hospital programme. In December 2017, Biofourmis announced that it had raised US$5.0 million in a Series A round of funding from NSI Ventures and Aviva Ventures, the strategic corporate venture arm of international insurer, Aviva plc. The company also entered into a collaboration with Mayo Clinic, which would enable them to assess de-identified healthcare data from clinical trials and Mayo’s expert medical insights.

New research from Israel shows the promise of using artificial intelligence as a second set of eyes to spot osteoporotic fractures and coronary vascular events.

Every healthcare organization wants to take the best care of their patients, increase compliance, and improve their bottom line. An EHR that can address these key goals is critical to a hospital’s success.

From innovations and emerging technology to the promise of regulatory relief for hospitals, healthcare has plenty to be grateful for this week and year round.

First movers such as Mount Sinai, Fresenius and Houston Methodist are running AI pilots and enabling employees to work alongside machines.

ClearData, IBM, PureStorage and others are positioning themselves for an emerging an environment where providers rely on a mix of public and private secure clouds for their data.